Glutamate treatment improved flavor, GABA content, phenolic compounds, and antioxidant capacity in fresh-cut carrots. Beneficial for maintaining nutritional quality and color.
Network pharmacology predicted molecular mechanisms of Coptis chinensis in Alzheimer's treatment, revealing active ingredients, targets, and a drug-component-disease-target network. Main signaling pathways involved PI3K-Akt, AGE-RAGE, MAPK, HIF-1, TNF, and relaxin. Berberine demonstrated strong affinity, informing future clinical research.
Researchers investigated the potential of Swertia chirayita, a plant with anti-inflammatory and antioxidant properties, to help with diabetic peripheral neuropathy (DPN), a complication of diabetes. Assessing oxidative stress's role in DPN is important for understanding and treating the condition.
Gardenia jasminoides Ellis (GJE) is a plant used in traditional medicine in China. Recent studies show it is effective for treating Alzheimer's, Parkinson's, and major depressive disorder. However, more research is needed.
Combining DL-3-n-butylphthalide (NBP) and dual antiplatelet therapy (DAPT) improves acute ischemic stroke in rats. It reduces neurological deficits, infarct area, and inflammation by suppressing the pyroptosis-inflammation pathway in brain tissues, especially in microglial cells.
Study evaluates the effects of berberine on Alzheimer's disease. Results show that it improves cognitive function and reduces the expression of amyloid precursor protein, suggesting potential neuroprotective effects. (40 words, 232 characters)
This study investigated the effectiveness and safety of Shugan Jieyu capsules in treating depression in epilepsy patients. Currently, there are no guidelines for depression treatment in epilepsy patients. It is important because antidepressants may worsen seizures.